Company / Operating Cash Flow per Share
Haemonetics Operating Cash Flow per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$3.77
FY2026
5-year range
$3.54 / $5.31
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#66 of 161
Health Care
What the data says
At $3.77, Haemonetics's operating cash flow per share ranks #66 of 161 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 9 years, ranging from $2.12 in FY2020 to $5.31 in FY2022.
Based on SEC 10-K filings.
3.77 in FY2026 with a 5-year CAGR of +2.4%.
Improved from $3.54 to $3.77 over the past 3 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +2.2%
- 5-Year CAGR
- +2.4%
- 10-Year CAGR
- -
Sector benchmark
#66 of 161 in Health CareTop 41% of 161This company $3.77 Sector average $6.64
▼
-43.3% below sector average
Key checks
Key Insights
- Ranks #66 out of 161 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2020.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $3.77 | - |
| FY2025 | - | - |
| FY2024 | $3.60 | +1.9% |
| FY2023 | $3.54 | -33.4% |
| FY2022 | $5.31 | +58.3% |
| FY2021 | $3.35 | +58.1% |
| FY2020 | $2.12 | -30.5% |
| FY2019 | $3.05 | +0.2% |
| FY2018 | $3.05 | -29.5% |
| FY2017 | $4.33 | +39.9% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026